Immuron Ltd is a commercial- and clinical-stage biopharmaceutical company focused on the development and commercialization of specifically targeted polyclonal antibodies. Its oral polyclonal antibodies offer delivery within the GI tract and can target viruses or bacteria and neutralize toxins at mucosal surfaces. The Company markets Travelan in Australia, an over-the-counter orally administered passive immunotherapeutic product indicated to reduce the risk of traveler's diarrhea and minor gastrointestinal disorders. Its products include Travelan, ProIBS and Protectyn. Its segments are Research and Development and Hyper-immune products, with Hyper-immune products generating maximum revenue. Australia generates maximum revenue.

CEO

ISIN

US45254U1016

Listings

0 Comments

Share your thoughts

FAQs

What is Immuron Limited stock price today?▼

The current price of IMRN.BOATS is $0.87 USD — it has increased by +1.77% in the past 24 hours. Watch Immuron Limited stock price performance more closely on the chart.

What is Immuron Limited stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Immuron Limited stocks are traded under the ticker IMRN.BOATS.

What is Immuron Limited market cap?▼

Today Immuron Limited has the market capitalization of 7M

When is the next Immuron Limited earnings date?▼

Immuron Limited is going to release the next earnings report on February 19, 2027.

What is Immuron Limited revenue for the last year?▼

Immuron Limited revenue for the last year amounts to 5.23M USD.

What is Immuron Limited net income for the last year?▼

IMRN.BOATS net income for the last year is -2.5M USD.

In which sector is Immuron Limited located?▼

Immuron Limited operates in the Other sector.

When did Immuron Limited complete a stock split?▼

Immuron Limited has not had any recent stock splits.